Surveillance or no surveillance for deep venous thrombosis and outcomes of critically ill patients

Objective: Surveillance ultrasounds in critically ill patients detect many deep venous thrombi (DVTs) that would otherwise go unnoticed. However, the impact of surveillance for DVT on mortality among critically ill patients remains unclear. Design: We are conducting a multicenter, multinational randomized controlled trial that examines the effectiveness of adjunct intermittent pneumatic compression use with pharmacologic thromboprophylaxis compared to pharmacologic thromboprophylaxis alone on the incidence of proximal lower extremity DVT in critically ill patients (the PREVENT trial). Enrolled patients undergo twice weekly surveillance ultrasounds of the lower extremities as part of the study procedures. We plan to compare enrolled patients who have surveillance ultrasounds to patients who meet the eligibility criteria but are not enrolled (eligible non-enrolled patients) and only who will have ultrasounds performed at the clinical team's discretion. We hypothesize that twice-weekly ultrasound surveillance for DVT in critically ill patients who are receiving thromboprophylaxis will have more DVTs detected, and consequently, fewer pulmonary emboli and lower all-cause 90-day mortality. Discussion: We developed a detailed a priori plan to guide the analysis of the proposed study and enhance the validity of its results.

[1]  Y. Mehta,et al.  Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trial , 2018, Trials.

[2]  R. Bellomo,et al.  Venous thromboembolic events in critically ill traumatic brain injury patients , 2017, Intensive Care Medicine.

[3]  S. Mehta,et al.  Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial , 2016, Trials.

[4]  M. Aboutanos,et al.  DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness , 2014, PloS one.

[5]  Philip P Goodney,et al.  Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. , 2012, Journal of vascular surgery.

[6]  Atul Nakhasi,et al.  Diagnostic errors in the intensive care unit: a systematic review of autopsy studies , 2012, BMJ quality & safety.

[7]  G. Guyatt,et al.  Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. , 2011, American journal of respiratory and critical care medicine.

[8]  G. Guyatt,et al.  Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.

[9]  D. Cook,et al.  Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients , 2010, Critical care medicine.

[10]  M. Ochsner,et al.  Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population. , 2008, The Journal of trauma.

[11]  G. Guyatt,et al.  Deep venous thrombosis: clinically silent in the intensive care unit. , 2005, Journal of critical care.

[12]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .